Insider · CIK 0001236397
Daniel Bradbury
Files at VANI (Vivani Medical, Inc.), CSTL (CASTLE BIOSCIENCES INC), EQ (Equillium, Inc.). First filing Nov 5, 2024, latest Feb 7, 2025.
Daniel Bradbury files SEC Form 4 as director, chair and 10% owner at CSTL (CASTLE BIOSCIENCES INC), and also at VANI (Vivani Medical, Inc.), EQ (Equillium, Inc.). Since Nov 5, 2024, Daniel Bradbury has reported 0 open-market buys worth $0 and 4 open-market sells worth $968k, the latest filed on Feb 7, 2025.
A track record needs three past buys with six months of prices behind them; Daniel Bradbury has 0, so none is measured yet.
The newest scored trade: sold $222k of CSTL on Feb 5, 2025, filed Feb 7, 2025, scored 27 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CSTL: CASTLE BIOSCIENCES INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 27Weak | CASTLE BIOSCIENCES INC | $222k 7,867 shares | -157% | - | |
| 43Moderate | CASTLE BIOSCIENCES INC | $229k 7,867 shares | -78% | - | |
| 36Weak | CASTLE BIOSCIENCES INC | $244k 7,867 shares | -52% | - | |
| 33Weak | CASTLE BIOSCIENCES INC | $273k 7,867 shares | -39% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 5, 2025 | CSTL Castle Biosciences, Inc. | 7,867 0.03% of outstanding | $221k | Feb 5, 2025 | $473k |
| Dec 3, 2024 | CSTL Castle Biosciences, Inc. | 15,734 0.06% of outstanding | $484k | Dec 3, 2024 | $733k |
Transactions
The newest 50 of 52 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | VANI Vivani Medical, Inc. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +36,516 | $1.22 | $45k | 36,516 | Jun 25, 2026 |
| May 28, 2026 | CSTL CASTLE BIOSCIENCES INC | AGrant or award Restricted Stock Unitsderivative | +11,766 | $0.00 | $0 | 11,766 | Jun 1, 2026 |
| May 28, 2026 | EQ Equillium, Inc. | AGrant or award Director stock option (right to buy)derivative | +70,000 | $0.00 | $0 | 70,000 | May 29, 2026 |
| May 22, 2026 | CSTL CASTLE BIOSCIENCES INC | MOption exercise Common Stock | +13,667 | - | - | 22,340 | May 27, 2026 |
| May 22, 2026 | CSTL CASTLE BIOSCIENCES INC | MOption exercise Restricted Stock Unitsderivative | -13,667 | $0.00 | $0 | 0 | May 27, 2026 |
| Jan 1, 2026 | VANI Vivani Medical, Inc. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +47,212 | $1.23 | $58k | 47,212 | Jan 5, 2026 |
| Jun 24, 2025 | VANI Vivani Medical, Inc. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +35,135 | $1.27 | $45k | 35,135 | Jun 26, 2025 |
| Jan 1, 2025 | VANI Vivani Medical, Inc. | DDisposition to issuer Non-Qualified Stock Option (right to buy)derivative | -237 | $1.16 | $275 | 49,822 | Jun 26, 2025 |
| May 21, 2025 | CSTL CASTLE BIOSCIENCES INC | MOption exercise Common Stock | +8,673 | - | - | 8,673 | May 23, 2025 |
| May 21, 2025 | CSTL CASTLE BIOSCIENCES INC | MOption exercise Restricted Stock Unitsderivative | -8,673 | $0.00 | $0 | 0 | May 23, 2025 |
| May 22, 2025 | CSTL CASTLE BIOSCIENCES INC | AGrant or award Restricted Stock Unitsderivative | +13,667 | $0.00 | $0 | 13,667 | May 23, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +90,000 | - | - | 90,000 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -90,000 | - | - | 0 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +36,000 | - | - | 36,000 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -36,000 | - | - | 0 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +28,708 | - | - | 28,708 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -28,708 | - | - | 0 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +36,000 | - | - | 36,000 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -36,000 | - | - | 0 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +38,000 | - | - | 38,000 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -38,000 | - | - | 0 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +50,000 | - | - | 50,000 | Feb 19, 2025 |
| Feb 14, 2025 | EQ Equillium, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -50,000 | - | - | 0 | Feb 19, 2025 |
| Feb 5, 2025 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By LLC10b5-1 | -5,017 | $28.17 | $141k | 0 | Feb 7, 2025 |
| Feb 5, 2025 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By Daniel Bradbury Irrevocable Descendant's Trust10b5-1 | -1,425 | $28.17 | $40k | 0 | Feb 7, 2025 |
| Feb 5, 2025 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By Annette Bradbury Irrevocable Descendant's Trust10b5-1 | -1,425 | $28.17 | $40k | 0 | Feb 7, 2025 |
| Jan 6, 2025 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By LLC10b5-1 | -1,530 | $28.39 | $43k | 8,504 | Jan 8, 2025 |
| Jan 6, 2025 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By Daniel Bradbury Irrevocable Descendant's Trust10b5-1 | -434 | $28.39 | $12k | 2,416 | Jan 8, 2025 |
| Jan 6, 2025 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By Annette Bradbury Irrevocable Descendant's Trust10b5-1 | -434 | $28.39 | $12k | 2,416 | Jan 8, 2025 |
| Jan 6, 2025 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By LLC10b5-1 | -3,015 | $29.41 | $89k | 5,489 | Jan 8, 2025 |
| Jan 6, 2025 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By Daniel Bradbury Irrevocable Descendant's Trust10b5-1 | -857 | $29.41 | $25k | 1,559 | Jan 8, 2025 |
| Jan 6, 2025 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By Annette Bradbury Irrevocable Descendant's Trust10b5-1 | -857 | $29.41 | $25k | 1,559 | Jan 8, 2025 |
| Jan 6, 2025 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By LLC10b5-1 | -472 | $29.82 | $14k | 5,017 | Jan 8, 2025 |
| Jan 6, 2025 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By Daniel Bradbury Irrevocable Descendant's Trust10b5-1 | -134 | $29.82 | $3,996 | 1,425 | Jan 8, 2025 |
| Jan 6, 2025 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By Annette Bradbury Irrevocable Descendant's Trust10b5-1 | -134 | $29.82 | $3,996 | 1,425 | Jan 8, 2025 |
| Jan 2, 2025 | EQ Equillium, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jan 6, 2025 |
| Jan 1, 2025 | VANI Vivani Medical, Inc. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +50,059 | $1.16 | $58k | 50,059 | Jan 3, 2025 |
| Dec 3, 2024 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By LLC10b5-1 | -4,669 | $30.95 | $145k | 10,382 | Dec 5, 2024 |
| Dec 3, 2024 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By Daniel Bradbury Irrecovable Descendant's Trust10b5-1 | -1,326 | $30.95 | $41k | 2,949 | Dec 5, 2024 |
| Dec 3, 2024 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By Annette Bradbury Irrecovable Descendant's Trust10b5-1 | -1,326 | $30.95 | $41k | 2,949 | Dec 5, 2024 |
| Dec 3, 2024 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By LLC10b5-1 | -348 | $31.32 | $11k | 10,034 | Dec 5, 2024 |
| Dec 3, 2024 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By Daniel Bradbury Irrecovable Descendant's Trust10b5-1 | -99 | $31.32 | $3,101 | 2,850 | Dec 5, 2024 |
| Dec 3, 2024 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By Annette Bradbury Irrecovable Descendant's Trust10b5-1 | -99 | $31.32 | $3,101 | 2,850 | Dec 5, 2024 |
| Nov 1, 2024 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By LLC10b5-1 | -1,322 | $33.90 | $45k | 18,746 | Nov 5, 2024 |
| Nov 1, 2024 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By Daniel Bradbury Irrecovable Descendant's Trust10b5-1 | -375 | $33.90 | $13k | 5,325 | Nov 5, 2024 |
| Nov 1, 2024 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By Annette Bradbury Irrecovable Descendant's Trust10b5-1 | -375 | $33.90 | $13k | 5,325 | Nov 5, 2024 |
| Nov 1, 2024 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By LLC10b5-1 | -2,686 | $34.92 | $94k | 16,060 | Nov 5, 2024 |
| Nov 1, 2024 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By Daniel Bradbury Irrecovable Descendant's Trust10b5-1 | -763 | $34.92 | $27k | 4,562 | Nov 5, 2024 |
| Nov 1, 2024 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By Annette Bradbury Irrecovable Descendant's Trust10b5-1 | -763 | $34.92 | $27k | 4,562 | Nov 5, 2024 |
| Nov 1, 2024 | CSTL CASTLE BIOSCIENCES INC | SOpen-market sale Common Stockindirect: By LLC10b5-1 | -1,009 | $35.33 | $36k | 15,051 | Nov 5, 2024 |
Questions about Daniel Bradbury
Answered from the filings on this page, as of the latest one.
Is Daniel Bradbury buying or selling?
Not in the last 12 months. Daniel Bradbury's latest open-market trade on SEC Form 4 was sold $222k of CSTL on Feb 5, 2025.
How did Daniel Bradbury's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Daniel Bradbury has 0.
Where does Daniel Bradbury file Form 4?
Daniel Bradbury has filed Form 4 at CSTL (CASTLE BIOSCIENCES INC); VANI (Vivani Medical, Inc.); EQ (Equillium, Inc.) as CHAIRMAN. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.